Trial Profile

Zotarolimus- versus sirolimus- versus paclitaxel-eluting stents for the prevention of coronary artery restenosis in patients with acute coronary syndromes or stable angina undergoing percutaneous coronary intervention

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 24 Aug 2012

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Zotarolimus (Primary) ; Paclitaxel; Sirolimus
Indications Acute coronary syndromes; Angina pectoris; Coronary artery disease; Coronary artery restenosis
Focus Therapeutic Use
Acronyms ZEST

11 Nov 2011 Serial angiographic follow-up results presented at the 23rd Annual Scientific Symposium on Transcatheter Cardiovascular Therapeutics.
23 Feb 2011 New trial record

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com